全文获取类型
收费全文 | 463475篇 |
免费 | 42807篇 |
国内免费 | 32553篇 |
专业分类
耳鼻咽喉 | 3562篇 |
儿科学 | 5740篇 |
妇产科学 | 5090篇 |
基础医学 | 51351篇 |
口腔科学 | 7663篇 |
临床医学 | 64630篇 |
内科学 | 63065篇 |
皮肤病学 | 5023篇 |
神经病学 | 22694篇 |
特种医学 | 17013篇 |
外国民族医学 | 275篇 |
外科学 | 42136篇 |
综合类 | 86578篇 |
现状与发展 | 114篇 |
一般理论 | 37篇 |
预防医学 | 33919篇 |
眼科学 | 13189篇 |
药学 | 50068篇 |
501篇 | |
中国医学 | 30148篇 |
肿瘤学 | 36039篇 |
出版年
2024年 | 1579篇 |
2023年 | 6791篇 |
2022年 | 17666篇 |
2021年 | 22564篇 |
2020年 | 17588篇 |
2019年 | 14438篇 |
2018年 | 14998篇 |
2017年 | 14306篇 |
2016年 | 13264篇 |
2015年 | 20544篇 |
2014年 | 25595篇 |
2013年 | 23317篇 |
2012年 | 34531篇 |
2011年 | 38824篇 |
2010年 | 25975篇 |
2009年 | 21175篇 |
2008年 | 26095篇 |
2007年 | 25899篇 |
2006年 | 24788篇 |
2005年 | 23857篇 |
2004年 | 15799篇 |
2003年 | 15074篇 |
2002年 | 12480篇 |
2001年 | 10856篇 |
2000年 | 10703篇 |
1999年 | 10923篇 |
1998年 | 6891篇 |
1997年 | 6810篇 |
1996年 | 5254篇 |
1995年 | 4950篇 |
1994年 | 4207篇 |
1993年 | 2708篇 |
1992年 | 3296篇 |
1991年 | 2817篇 |
1990年 | 2376篇 |
1989年 | 2112篇 |
1988年 | 1749篇 |
1987年 | 1573篇 |
1986年 | 1322篇 |
1985年 | 944篇 |
1984年 | 487篇 |
1983年 | 370篇 |
1982年 | 203篇 |
1981年 | 231篇 |
1980年 | 154篇 |
1979年 | 204篇 |
1978年 | 73篇 |
1977年 | 53篇 |
1974年 | 43篇 |
1972年 | 37篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
PRO 1000 V3型心电监护仪LCD逆变器的升级及注意事项 总被引:1,自引:0,他引:1
介绍了该型心电监护仪黑屏故障的常见原因,对升级前后的LCD逆变器电路作了对比分析,并详细介绍了升级更换的方法和注意事项。 相似文献
42.
Gelin Xu Xinfeng Liu Wusheng Zhu Qin Yin Renliang Zhang Xiaobing Fan 《Blood coagulation & fibrinolysis》2007,18(2):193-197
This study evaluated the safety and efficacy of batroxobin in treating hyperfibrinogenemia for secondary stroke prevention. Patients with ischemic stroke or transient ischemic attack (TIA) were measured for plasma fibrinogen levels. Selected participants had concomitant hyperfibrinogenemia (plasma fibrinogen > or = 3.0 g/l). Patients enrolled between 1 July 2003 and 31 December 2004 were treated with batroxobin; patients enrolled between 1 January 2002 and 30 June 2003 were treated without batroxobin. Batroxobin was administered intermittently via intravenous injection at 3-monthly intervals. Patients in both groups were followed for 1 year. Any cerebrovascular events and suspected adverse events were recorded. In total, 112 ischemic stroke/TIA patients with concomitant hyperfibrinogenemia were enrolled, 52 being treated with batroxobin and 60 without batroxobin. Six patients (11.5%) with batroxobin and 16 patients (26.7%) without batroxobin had recurrent cerebral ischemic events during follow-up. Stroke/TIA recurrence in patients without batroxobin was higher than that in patients with batroxobin (P < 0.05). Two patients with batroxobin and two patients without batroxobin developed hemorrhagic stroke during follow-up. There were five deaths (9.6%) in the batroxobin group, and seven deaths (11.7%) in the nonbatroxobin group during follow-up (P > 0.05). Intermittent intravenous injection of batroxobin can efficiently reduce the risk for stroke/TIA recurrence in patients with concomitant hyperfibrinogenemia. 相似文献
43.
44.
J Chhabra Y-Z Li H Alkhouri A E Blake Q Ge C L Armour J M Hughes 《The European respiratory journal》2007,29(5):861-870
Degranulating mast cells are increased in the airway smooth muscle (ASM) of asthmatics, where they may influence ASM function. The aim of the present study was to determine whether histamine and tryptase modulate ASM cell granulocyte-macrophage colony-stimulating factor (GM-CSF) and RANTES (regulated on activation, normal T-cell expressed and secreted) release and also to examine which receptors are involved in this release. Confluent, quiescent ASM cells from asthmatic and nonasthmatic donors were treated with histamine (1 microM-100 microM) with and without histamine receptor antagonist pre-treatment, or the protease-activated receptor (PAR)-2 agonists tryptase (0.5-5 nM) and SLIGKV (100 and 400 microM). The cells were then stimulated with interleukin (IL)-1beta and/or tumour necrosis factor (TNF)-alpha (10 ng.mL(-1)) or left unstimulated for 24 h. Release of GM-CSF and RANTES was determined by ELISA and prostaglandin (PG)E(2) measured by enzyme immunoassay. Neither histamine nor tryptase induced ASM GM-CSF or RANTES secretion. However, histamine increased IL-1beta-induced GM-CSF release and markedly reduced TNF-alpha-induced RANTES release by both asthmatic and nonasthmatic cells to a similar extent, but did not modulate PGE(2) release. All changes involved activation of the histamine H1 receptor as they were partially or fully blocked by chlorpheniramine, but not ranitidine. Tryptase, via its proteolytic activity, also potentiated GM-CSF, but not RANTES, release from asthmatic and nonasthmatic ASM cells induced by both cytokines. PAR-2 involvement in the tryptase potentiation was unlikely because SLIGKV had no effect. In conclusion, mast cells, through histamine and tryptase, may locally modulate airway smooth muscle-induced inflammation in asthma. 相似文献
45.
近十年高血压病中医研究概况 总被引:1,自引:0,他引:1
为了促进中医药治疗高血压病的进一步发展,深入进行高血压病中医的病因病机、治法方药、作用机制的相关研究,本文对近十年有代表性的文献进行归纳分析。 相似文献
46.
47.
案例教学法在护理伦理学中的应用分析 总被引:1,自引:1,他引:0
目的分析案例式教学在护理伦理学教学中应用的效果,以探讨适合护理伦理学的教学方法。方法采用传统教学法与案例教学法相对照进行护理伦理学的授课,对528名授课学生进行问卷调查并收集资料。结果92.4%的学生认为案例教学法能激发学习兴趣,87.2%的学生认为能调动学习的积极性,82.6%的学生认为有利于对知识的理解,72.1%的学生认为能培养思维和决策能力,68.0%的学生认为能增进师生互动。结论案例教学法可提高教学效果。培养学生的批判性思维能力。 相似文献
48.
以院务公开为根本 积极探索治理医药购销领域商业贿赂长效机制 总被引:1,自引:1,他引:0
49.
50.
晕可消胶囊治疗椎—基底动脉缺血性眩晕疗效观察及其对红细胞膜流动性的影响 总被引:1,自引:1,他引:0
李新毅 《山西中医学院学报》2004,5(4):19-20
目的:较大样本观察晕可消胶囊治疗椎-基底动脉缺血性眩晕疗效及其对红细胞膜流动性的影响。方法:符合入选标准的门诊病例203例随机分为观察组(晕可消组)102例,对照组(维脑路通组)101例,治疗10d后行疗效评定并以荧光偏振法检测红细胞膜流动性的变化。结果:观察组疗效优于对照组,并显著改善了红细胞膜的流动性。结论:晕可消胶囊具有改善红细胞膜流动性作用,用于治疗椎-基底动脉缺血性眩晕疗效肯定,值得推广。 相似文献